Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Expert Opinion on Pharmacotherapy
|
September 22, 2017
Are newly launched pharmacotherapies efficacious in treating idiopathic pulmonary fibrosis? Or is there still more work to be done?
Riccardo Inchingolo, Carola Condoluci, Andrea Smargiassi, et al.
The European Respiratory Journal
|
April 20, 2019
Impact of chest imaging quality on the diagnosis of the usual interstitial pneumonia pattern: a hub and spoke study
Giacomo Sgalla, Anna Rita Larici, Antonina Re, et al.
Respirology (Carlton, Vic.)
|
August 21, 2023
A randomized trial of pamrevlumab in patients with COVID-19 pneumonia
Giacomo Sgalla, Paolo Maria Leone, Gina Gualano, et al.
Respiratory Research
|
September 28, 2024
Reliability of crackles in fibrotic interstitial lung disease: a prospective, longitudinal study
Giacomo Sgalla, Jacopo Simonetti, Arianna Di Bartolomeo, et al.
Chest
|
November 17, 2021
Association of BMI and Change in Weight With Mortality in Patients With Fibrotic Interstitial Lung Disease
Alessia Comes, Alyson W Wong, Jolene H Fisher, et al.
Annals of the American Thoracic Society
|
December 13, 2021
Prescribing Patterns and Tolerability of Mycophenolate and Azathioprine in Patients with Nonidiopathic Pulmonary Fibrosis Fibrotic Interstitial Lung Disease
Alyson W Wong, Yet H Khor, Kathryn Donohoe, et al.
The European Respiratory Journal
|
March 11, 2022
Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry
Nathan Hambly, M Malik Farooqi, Anna Dvorkin-Gheva, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Expert Opinion on Pharmacotherapy
|
September 22, 2017
Are newly launched pharmacotherapies efficacious in treating idiopathic pulmonary fibrosis? Or is there still more work to be done?
Riccardo Inchingolo, Carola Condoluci, Andrea Smargiassi, et al.
The European Respiratory Journal
|
April 20, 2019
Impact of chest imaging quality on the diagnosis of the usual interstitial pneumonia pattern: a hub and spoke study
Giacomo Sgalla, Anna Rita Larici, Antonina Re, et al.
Respirology (Carlton, Vic.)
|
August 21, 2023
A randomized trial of pamrevlumab in patients with COVID-19 pneumonia
Giacomo Sgalla, Paolo Maria Leone, Gina Gualano, et al.
Respiratory Research
|
September 28, 2024
Reliability of crackles in fibrotic interstitial lung disease: a prospective, longitudinal study
Giacomo Sgalla, Jacopo Simonetti, Arianna Di Bartolomeo, et al.
Chest
|
November 17, 2021
Association of BMI and Change in Weight With Mortality in Patients With Fibrotic Interstitial Lung Disease
Alessia Comes, Alyson W Wong, Jolene H Fisher, et al.
Annals of the American Thoracic Society
|
December 13, 2021
Prescribing Patterns and Tolerability of Mycophenolate and Azathioprine in Patients with Nonidiopathic Pulmonary Fibrosis Fibrotic Interstitial Lung Disease
Alyson W Wong, Yet H Khor, Kathryn Donohoe, et al.
The European Respiratory Journal
|
March 11, 2022
Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry
Nathan Hambly, M Malik Farooqi, Anna Dvorkin-Gheva, et al.
Page
of 2